Resolution for winding up (MVL)
ASTRAZENECA INVESTMENTS LIMITED
A special and ordinary resolution was passed to voluntarily wind up AstraZeneca Investments Limited, appointing Stephen Robert Cork and Anthony Malcolm Cork as joint liquidators.
Notice details
- Company
- ASTRAZENECA INVESTMENTS LIMITED
- Company number
- 02728922
- Registered office
- 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA
- Principal trading address
- N/A
- Liquidator(s)
- Stephen Robert Cork; Anthony Malcolm Cork
- Liquidator number(s)
- IP No. 8627; IP No. 009401
- Date of appointment
- 28 July 2026
- Contact
- The Liquidators, telephone: 0207 268 2150; Alternative contact: Irfan Sadiq, Email: [email protected]
- Director
- Hannah Tattersall
Planning a solvent wind-down or restructure?
A members' voluntary liquidation is a solvent, orderly closure — often part of retirement, a group restructure, or moving on to the next venture. K2 has advised UK company directors since 1990 on restructuring and what comes next. If that's on your horizon, talk to us.
Related guidance
Free, practical guides from K2 on what this kind of notice means for directors.
More liquidation notices
Source: The London Gazette and Companies House. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright. This page is provided by K2 Partners for information only and is not legal or financial advice.